The Effects of Continuous 28-Day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-Day (5/28) Treatment (P04601AM1)(COMPLETED)
This study has been completed.
Study NCT00392171.
Last updated on May 13, 2009.
Information provided by Schering-Plough
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
